The Time is Now:
Accelerating Life-Changing
Treatments for NF
The Time is Now:
Seize It with Us
Reinforce the importance of immediate action and how the Fund will use
donations to create a lasting legacy in NF treatment.
The Momentum is Here
First drug approved, second at FDA.
The Science is Ready
Breakthroughs are transforming treatments.
Pharma Wants to Engage with CTF
But they won’t wait.
The Rapid Rise of Technology
Al and tech are unlocking unimaginable possibilities.
Proven Plan
A scalable, global strategy that works.
Seizing a Historic Opportunity
Outline points such as the recent FDA approval, breakthrough science, growing pharma interest,
and the rapid rise of new technologies like Al in research.
Trusted Partner
Uniting patients, clinicians, scientists, pharma.
Robust Innovation Pipeline
A rich, diverse research portfolio that follows the most promising science to completion.
End-to-End Solutions
We drive early-stage discovery, moving the most promising science toward real-world therapies.
CTF Industry Expertise
In-house pharma experts with proven know-how.
Timeline Headline
Why You
( Donor )
Thanks and acknowledgment of their
incredible past support Dynamic data
visuals to highlight CTF progress.
2,309,098
Lorem ipsum dolor sit amet, consectetur
adipiscing elit amet do.
150%
Lorem ipsum dolor sit amet, consectetur
adipiscing elit amet do.
200x
Lorem ipsum dolor sit amet, consectetur
adipiscing elit amet do.
Example Name
Company/Position
“Lorem ipsum dolor sit amet, consectetur adipiscing elit amet do.”
Example Name
Company/Position
“Lorem ipsum dolor sit amet, consectetur adipiscing elit amet do.”
Example Name
Company/Position
About the Fund
Explain the Fund's mission to drive NF treatments from discovery to market through strategic
investments, clinical trials, and drug screening.
Strategic Commercial
Question We Are Answering:
How can we accelerate the development of NF relevant treatments through targeted investments?
Purpose
- What we do: We identify the most promising treatments and make strategic, targeted investments. We provide companies (primarily biotechs) with the resources, credibility and support they need to move faster and unlock additional funding.
- How we do it: Our strategic investments lower the barrier to entry for companies, spurring greater interest and involvement in NF.
- What it means: When these treatments succeed, we reinvest the returns, creating a cycle of innovation
and progress.
Why it Matters
Instead of waiting for the system to change, we work to eliminate barriers to discovery.
By proactively identifying the most promising treatments, we provide our partners with a ready-to-go solution to join us in driving progress.
Strategic Commercial
Question We Are Answering:
How can we accelerate the development of NF relevant treatments through targeted investments?
Purpose
- What we do: We identify the most promising treatments and make strategic, targeted investments. We provide companies (primarily biotechs) with the resources, credibility and support they need to move faster and unlock additional funding.
- How we do it: Our strategic investments lower the barrier to entry for companies, spurring greater interest and involvement in NF.
- What it means: When these treatments succeed, we reinvest the returns, creating a cycle of innovation
and progress.
Why it Matters
Instead of waiting for the system to change, we work to eliminate barriers to discovery.
By proactively identifying the most promising treatments, we provide our partners with a ready-to-go solution to join us in driving progress.
Strategic Commercial
Question We Are Answering:
How can we accelerate the development of NF relevant treatments through targeted investments?
Purpose
- What we do: We identify the most promising treatments and make strategic, targeted investments. We provide companies (primarily biotechs) with the resources, credibility and support they need to move faster and unlock additional funding.
- How we do it: Our strategic investments lower the barrier to entry for companies, spurring greater interest and involvement in NF.
- What it means: When these treatments succeed, we reinvest the returns, creating a cycle of innovation
and progress.
Why it Matters
Instead of waiting for the system to change, we work to eliminate barriers to discovery.
By proactively identifying the most promising treatments, we provide our partners with a ready-to-go solution to join us in driving progress.
NF Therapeutics Accelerator Fund
Two Strategies to Maximize Returns and Drive NF Breakthroughs
Direct Investment
We invest directly into a commercial entity - injecting capital into companies that are actively developing a treatment relevant to NF (usually early-stage biotechs).
By doing this, we help them advance their research and also position ourselves to share in the financial returns if the treatment succeeds.
Indirect Investment
By doing this, we help them advance their research and also position ourselves to share in the financial returns if the treatment succeeds.
By enabling the quick and easy testing of these compounds, we make assets more attractive for further investment and share in the financial returns if successful, reinvesting them into NF research and development.
By working across biotech startups and large pharma, we reduce risks,
remove barriers, and generate financial returns that fund further NF research.
This dual approach positions CTF to harness the agility of early-stage
innovation and the scale of pharma, driving progress from every angle.
“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.”
Example Name
Company/Position
Exclusive Opportunities for Visionary Donors
Outline the exclusive experiences and recognitions
for high-level donors, including:
Benefit Example
Lorem ipsum dolor sit amet, consectetur
adipiscing elit amet do.
Benefit Example
Lorem ipsum dolor sit amet, consectetur
adipiscing elit amet do.
Benefit Example
Lorem ipsum dolor sit amet, consectetur
adipiscing elit amet do.
Contact
Lorem ipsum dolor sit amet,
consectetur adipiscing elit, sed do
eiusmod tempor incididunt ut labore et
dolore magna aliqua.
Email Address:
Phone Number:
Sign Up for our Newsletter
Join our mailing list for news, exclusive resources, events and opportunities.
"*" indicates required fields
